Condition: Cognitive Impairment · Sponsor: Anahuac University
Cognitive impairment is one of the fastest growing diseases in the last decades, given the significant increase in senior citizen population in Mexico and the world. Several studies have discussed the gut-microbiota-brain axis. It has been demonstrated that a balanced gut microbiota, prevents an increase in pro-inflammatory cytokines that affect specific brain areas; having an important impact at the cortical level of the hippocampus which translates to diminished cognitive function and the start of cognitive impairment symptoms. After multiple studies on the effect of the administration of symbiotics in animal models in cognition and memory, there have been positive results, observing improvement in cognition and decrement in inflammatory cytokines at hippocampus level.
This description comes directly from the study's public registry record.
JOSE JUAN ANTONIO IBARRA ARIAS, MEDICO CIRUJANO · 5554197603 · jose.ibarra@anahuac.mx
ADELA ESCANDON CESARMAN, MEDICO CIRUJANO · 5520459938 · adela.escandon.cesarman@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital ABC Santa Fe | Mexico City, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05688618